Scribe Therapeutics Inc. SCTX
Set alert
15.42 USD -2.02 -11.58%
At close · Oct 30
15.25 -0.17 -1.10%
After hours · Oct 30, 4:00 PM ET
14.77 Day range 17.00
13.50 52-week range 39.60
- YTD
- -18.71%
- 1 year
- -18.71%
- Open
- 17.00
- Prev close
- 17.44
- Mkt cap
- 291.93M
- Vol
- 480.71K
- Avg vol
- 373.91K
- EPS
- -3.84
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.77
- High
- 17.00
Financials — quick view
SCTX Revenue — quarterly 1.92M
SCTX Net income — quarterly -6.48M
SCTX EPS — quarterly -2.62
News
- Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
- Scribe Therapeutics: Underrated In-Vivo Gene Therapy Developer With Near-Term Catalyst
- Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday
- Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up
- Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock Rated “Moderate Buy” by Wall Street Analysts
- Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
- Scribe Therapeutics to Participate in Upcoming Investor Conferences
- Here Are Monday’s Top Wall Street Analyst Research Calls: AGCO Corporation, Deere & Co., Edison International, Lumentum Holdings, PG&E, Sempra Energy, STAG Industrial, Ticketplus, and More
- Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters' Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
- Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
Your note
Sign in to keep a note on SCTX — it syncs with the Stock Master app.